Systemic Sclerosis (Scleroderma) and Medical Cannabis
Systemic sclerosis (scleroderma) and medical cannabis meet in only a handful of studies. A synthetic cannabinoid called lenabasum, which acts on the CB2 receptor, was tested in small early trials for skin thickening. The THC and CBD products sold through state medical programs have not been studied in this disease at all. Smoke and vapor travel through the lungs, which systemic sclerosis often scars, so how you would use cannabis matters as much as whether you use it.
What is known comes from two reports on small lenabasum trials, one experiment in mice and several reviews; each study on this page is labeled by who was studied. The full picture starts at what the research shows. This guide does not replace your rheumatologist.
When systemic sclerosis needs urgent care: blood pressure spikes, sudden breathlessness, darkening fingertips
Some turns of this disease cannot wait for a scheduled visit. If any of the signs below appear, get emergency care or call your rheumatology team the same day. Questions about cannabis can come later.
- Your home blood pressure reading jumps well above your usual numbers, especially with a pounding headache, blurred vision or much less urine. These are the warning signs of scleroderma renal crisis, a kidney emergency.
- You become short of breath suddenly, or have chest pain or a racing heart.
- A fingertip turns black or deep purple and stays that way after warming, or a finger ulcer becomes hot, swollen and painful.
- One leg swells and aches, or breathlessness comes on with chest pain. People with systemic sclerosis had about three and a half times the rate of blood clots in a large population study (hazard ratio 3.47, range 2.14 to 5.64) [1]. That is a link, not proof of a cause.
- You faint, or feel confused or unusually drowsy.
What to tell the emergency team
- That you have systemic sclerosis, which form, and which organs are involved.
- Every medicine you take, including blood pressure pills, immunosuppressants and blood thinners.
- Any cannabis or CBD product used in the past few days, with the label if you have it.
Call 911 · How systemic sclerosis affects the lungs, heart and kidneys
Who wrote and checked this page
- Each figure from a study is tied to that study in the reference list at the bottom, with its year and design.
- Every study is tagged: people, mice, a lab dish, or a study about another treatment entirely.
- Trial drugs such as lenabasum are kept apart from the THC and CBD products a state program sells.
- The medical content is reviewed by Dr. Weedy physicians with active state licenses. See our physicians.
Tight skin, white fingers in the cold, a quiet worry about your lungs: what systemic sclerosis takes from daily life
For many people it begins with fingers that turn white, then blue, in an air-conditioned store. Then the skin over the hands gets puffy and tight, rings stop fitting, and buttons become a project. A rheumatologist puts a name to it, and the name comes with a list of tests for organs you never thought about.
Living with it means planning around cold, guarding fingertips that crack and heal slowly, and waiting each year for the breathing test and the heart scan. Reflux keeps you up. Itching keeps you up. Fatigue is there either way. Somewhere in that, the question about cannabis comes up, from a friend, a forum or a dispensary ad.
Fingers that hurt in the cold
Raynaud attacks, ulcers on the fingertips and stiff hands are often the hardest part of an ordinary day, from typing to opening a jar.
The yearly lung and heart check
Breathing tests, chest scans and echocardiograms decide a lot. Waiting for the results is its own kind of strain, and it shapes every decision about anything you inhale.
Years of strong medicines
Immunosuppressants, blood vessel drugs and acid reducers add up. It is fair to ask what else might ease pain or sleep, and what would clash with that list.
Below is what the research on cannabinoids in systemic sclerosis actually contains, without hype and without scare stories, so you can take a clear question to your rheumatologist.
Newly diagnosed, living with lung involvement, or already using cannabis: where to start
Pick the line closest to where you are now. The matching part of this guide opens below.
You were diagnosed recently
Start with what the disease is and how it usually runs. The form you have, limited or diffuse, and your antibody result shape most of what comes next.
Your scans show lung involvement
Interstitial lung disease or pulmonary hypertension changes the cannabis question. Anything smoked or vaped goes straight to the tissue that is scarring.
You take mycophenolate, nifedipine, sildenafil or a blood thinner
The most practical question is how THC or CBD would sit next to these. The known overlaps are sedation, blood pressure and liver enzymes.
You already use cannabis
Tell your rheumatologist which product, how much and how you take it. If your lungs are involved, the form you use deserves its own conversation.
You already have a medical card
A new diagnosis or a new medicine is worth mentioning at your next evaluation, so the physician can look at your plan again.
What is systemic sclerosis? Scleroderma, connective tissue disease and ICD-10 codes
Systemic sclerosis (SSc) is a chronic autoimmune disease of connective tissue. The immune system damages small blood vessels and drives fibrosis, a buildup of scar-like collagen, in the skin and in organs such as the lungs, gut, heart and kidneys. It is not contagious, there is no cure yet, and treatment depends on which organs are involved [2].
Scleroderma is the umbrella word for hard skin. Localized scleroderma (morphea and linear scleroderma) stays in the skin and tissue under it. Systemic sclerosis, also called systemic scleroderma, reaches internal organs. When people say “scleroderma” about lungs or kidneys, they mean systemic sclerosis.
It is rare. A review counted about 250 people with SSc per million in the United States and about 20 new cases per million each year [3].
Which form is on your chart?
Rheumatologists name the form by how far skin thickening spreads. Your clinic notes or patient portal usually say “limited cutaneous” or “diffuse cutaneous.”
Limited cutaneous SSc
Skin thickening stays on the fingers, hands, forearms below the elbow and face. It often follows years of Raynaud attacks. The older name CREST lists its features: calcinosis, Raynaud’s, esophagus problems, sclerodactyly, telangiectasias.
Watched most closely
Pulmonary arterial hypertension, gut. Often anti-centromere antibodies.
Diffuse cutaneous SSc
Thickening spreads above the elbows and knees or onto the trunk, often within the first few years. Organ changes tend to start earlier.
Watched most closely
Lungs (interstitial lung disease), kidneys, heart. Often anti-Scl-70 or anti-RNA polymerase III.
SSc sine scleroderma
Internal organs and antibodies show the disease, but the skin does not thicken. It is less common and easy to miss.
Watched most closely
Lungs, gut, heart, depending on the antibody.
Ask your rheumatologist which form is written in your record; it also tells you which organ checks matter most for you.
ICD-10 codes for systemic sclerosis
Doctors and insurers code systemic sclerosis under M34 in ICD-10-CM [4]. The older ICD-9 code was 710.1. A medical card evaluation looks at the diagnosis itself, but the code helps when you gather records.
| Code | What it means |
|---|---|
| M34.0 | Progressive systemic sclerosis |
| M34.1 | CR(E)ST syndrome, the limited form |
| M34.2 | Systemic sclerosis induced by a drug or chemical |
| M34.81 | Systemic sclerosis with lung involvement |
| M34.82 | Systemic sclerosis with myopathy (muscle involvement) |
| M34.83 | Systemic sclerosis with polyneuropathy (nerve involvement) |
| M34.89 | Other systemic sclerosis |
| M34.9 | Systemic sclerosis, unspecified |
What causes systemic sclerosis, and is it hereditary?
Nobody knows exactly what starts it. Researchers describe three processes feeding each other: injury to the lining of small blood vessels, an immune system that turns on the body’s own proteins, and fibroblasts, the cells that make collagen, that keep laying down scar tissue long after any need for it [3].
Systemic sclerosis is not passed from parent to child the way a single-gene condition is. Genes raise the odds a little, and most people with SSc have no relative with it.
Studies link some outside factors with it, but none has been shown to cause it. Work exposure to silica dust and some organic solvents comes up most often in studies. Women are diagnosed several times more often than men, usually between their 30s and 50s [2].
Systemic sclerosis symptoms and early signs: hands, skin, gut, eyes and brain
The first sign is usually Raynaud’s phenomenon: fingers or toes go white, then blue, then red when cold or stressed. Puffy fingers often follow. After that, symptoms depend on the form and on which organs the disease reaches. Pick an area to read about it.
Hands
- Raynaud attacks that last longer and hurt more than ordinary cold fingers.
- Swollen, sausage-like fingers in the early phase.
- Sclerodactyly: tight, shiny skin that slowly curls the fingers and limits making a fist.
- Digital ulcers: painful sores on fingertips or over knuckles that heal slowly and can get infected.
- Calcinosis: chalky lumps of calcium under the skin, which can break through and drain.
Skin
Thickened, hard skin that does not pinch up, starting at the fingers and face. The mouth opening can shrink. Small red spots of dilated vessels (telangiectasias) show on the face, lips and hands. Itching is common in the early, inflammatory phase of diffuse disease. Hair can thin or stop growing where skin has thickened, and skin may darken or lighten in patches.
Gut
The gut is affected in most people with SSc. The esophagus moves food down less well, so heartburn, reflux and food sticking on the way down are common. Lower down, slow movement leads to bloating, early fullness, constipation, or diarrhea from bacterial overgrowth. Weight loss is a sign to raise with the team.
Joints and pain
It often hurts, and pain comes from several places: Raynaud attacks and ulcers in the fingers, stiff joints and tendons (sometimes with a creaking feel under the skin), muscle inflammation, calcinosis lumps and reflux. Many people also describe deep fatigue and poor sleep, which make pain harder to bear.
Eyes, brain and hair
Dry, gritty eyes and dry mouth are common, sometimes with an overlapping Sjögren’s syndrome. Tight eyelid skin can make blinking less complete. The brain is rarely affected directly. A severe headache with vision changes points to a blood pressure crisis, which is an emergency. Nerve problems such as numbness in a hand (carpal tunnel) or the face do occur but are uncommon. Hair loss is usually limited to thickened skin.
Lungs, heart and kidneys: systemic sclerosis complications you should know
Organ involvement is what makes systemic sclerosis serious, and most of it can be caught early with regular tests. These are the ones rheumatologists watch.
Lungs: interstitial lung disease and pulmonary hypertension
Interstitial lung disease (SSc-ILD) is scarring of the lung tissue between the air sacs. It is the leading cause of serious illness in SSc and is more common in the diffuse form and with anti-Scl-70 antibodies. It can be silent at first, so breathing tests (FVC and DLCO) and a high-resolution CT scan are repeated over time.
Pulmonary arterial hypertension (PAH) is high pressure in the lung arteries, which strains the right side of the heart. It is more typical of the limited form. Breathlessness on stairs and swollen ankles are the usual signs; an echocardiogram is the screening test.
Both matter for cannabis: smoke and hot vapor reach exactly the tissue that is scarring, and THC can speed the heart. See what each form avoids.
Heart
Fibrosis can reach the heart muscle and its electrical system, causing palpitations, skipped beats or fluid around the heart. Many cases are found on routine ECG or echo before symptoms appear. New palpitations, fainting or chest pain need prompt review.
Kidneys and blood pressure
Scleroderma renal crisis is a sudden rise in blood pressure with fast-falling kidney function. It is most likely in early diffuse disease, with anti-RNA polymerase III antibodies, and after high doses of steroids. Many people are asked to check blood pressure at home for this reason. It is treated urgently with ACE inhibitors. Kidney injury from other causes is covered on our page on acute kidney injury.
Blood clots in veins
A population study from British Columbia compared 1,245 people with SSc with 12,670 matched people without it. Clots in the veins were more common with SSc: 6.56 against 1.37 per 1,000 person-years [1]. The gap was largest in the first year after diagnosis. The study shows a link and does not explain its cause.
How much higher is the risk of blood clots with systemic sclerosis?
How to read it: each row compares people with SSc with similar people without it. The dot is the study’s best estimate; the line around it is the range the true value likely falls in. The gray vertical line marks no difference. Everything to its right means clots were more frequent with SSc.
Show as a table
| Clot | Hazard ratio (95% CI) | Rate with SSc | Rate without SSc | Hazard ratio, first year |
|---|---|---|---|---|
| Pulmonary embolism | 3.73 (1.98-7.04) | 3.47 per 1,000 person-years | 0.78 per 1,000 person-years | 32.77 [1] |
| Deep vein thrombosis | 2.96 (1.54-5.69) | 3.48 per 1,000 person-years | 0.76 per 1,000 person-years | 8.5 [1] |
| Any vein clot | 3.47 (2.14-5.64) | 6.56 per 1,000 person-years | 1.37 per 1,000 person-years | 12.03 [1] |
This is a disease fact, not a cannabis finding. It matters because any new medicine or product, cannabis included, should be reviewed by someone who knows your clot history and whether you take a blood thinner.
Is systemic sclerosis fatal? · Inhaled cannabis and the lungs
How is systemic sclerosis diagnosed? Antibodies, ACR/EULAR criteria and tests
A rheumatologist makes the diagnosis from the whole picture: Raynaud’s, skin thickening, changes in the tiny vessels at the nail fold seen through a magnifier (nailfold capillaroscopy), and antibodies in the blood. There is no single test that settles it.
For research and for consistency, doctors use the 2013 ACR/EULAR classification criteria [5]. Each feature earns points, and a total of 9 or more classifies a person as having SSc. Skin thickening of the fingers of both hands that reaches above the knuckles counts 9 points on its own. Other items include fingertip ulcers or pits, telangiectasias, abnormal nailfold vessels, lung involvement, Raynaud’s and the specific antibodies.
Which antibody is named on your lab report?
Look in the “autoantibodies” or “ENA panel” part of the report, or in your patient portal. If the result is not there, your rheumatologist can tell you which one was found.
Pick the antibody on your report.
- Anti-centromere (ACA, CENP-B)
- Usually seen with the limited form.
- Doctors keep a close eye on pulmonary arterial hypertension, fingertip ulcers and calcinosis.
- 32.2% [6]
- of 357 people with SSc in one Japanese cohort had anti-CENP-B [6]
- Anti-Scl-70 (anti-topoisomerase I)
- Usually seen with the diffuse form.
- Doctors keep a close eye on the lungs, with regular breathing tests and CT scans for interstitial lung disease.
- 26.9% [6]
- of 357 people with SSc in one Japanese cohort had anti-topoisomerase I [6]
- Anti-RNA polymerase III
- Usually seen with the diffuse form, often with fast-spreading skin thickening.
- Doctors keep a close eye on blood pressure and the kidneys, because renal crisis is more likely.
- ANA positive, no specific antibody named
- ANA is positive in most people with SSc, but also in many people without it.
- It does not point to a form. Ask whether a full SSc antibody panel was run.
- Not sure
- Your antibody result helps predict which organs need watching.
- Ask your rheumatologist which antibody was found and what it means for your checkups.
A reading aid, not a diagnosis: antibodies point to patterns, and your rheumatologist reads them with everything else.
Lab methods differ, too. In a study of a newer antibody test, the conventional immunoblot missed 19% of positive results [7]. This was a test-method study, not a cannabis study.
Tests that check the organs
Nailfold capillaroscopy
A painless look at the small vessels at the base of the nails. Enlarged or missing loops support the diagnosis, sometimes years before the skin changes.
Breathing tests and CT
Pulmonary function tests measure how much air you move (FVC) and how well oxygen passes into blood (DLCO). A high-resolution CT shows scarring. Both are usually repeated, especially in the first years.
Echocardiogram and ECG
The echo estimates pressure in the lung arteries and looks at heart muscle; the ECG checks the rhythm. A right heart catheter confirms pulmonary hypertension if screening suggests it.
Blood pressure and kidney tests
Home readings, creatinine and urine tests look for early signs of renal crisis, most of all in early diffuse disease.
How is systemic sclerosis treated? BSR guidelines and organ-specific care
Treatment is chosen organ by organ. The British Society for Rheumatology (BSR) guideline, like its European and American counterparts, sorts care by what the disease is doing: blood vessels, skin, lungs, kidneys, gut [8]. Pick a problem to see the usual medicine families.
Raynaud’s and digital ulcers
Keeping the whole body warm comes first. Calcium channel blockers such as nifedipine widen small vessels; PDE5 inhibitors such as sildenafil and, for severe cases, intravenous iloprost are added. Bosentan may be used to prevent new ulcers.
Skin thickening
In early diffuse disease, immunosuppressants such as mycophenolate or methotrexate are used to slow skin change. Selected people with severe, rapidly progressing disease are considered for stem cell transplant at specialist centers.
Interstitial lung disease
Mycophenolate is the usual first choice, with cyclophosphamide as an alternative. The antifibrotic nintedanib slows the loss of lung function, and tocilizumab is used in some people with early ILD. Pulmonary hypertension has its own medicines.
Renal crisis
ACE inhibitors, started fast and raised until blood pressure is controlled. High-dose steroids are avoided where possible because they raise the risk.
Reflux and slow gut
Proton pump inhibitors for reflux, prokinetic drugs to help the gut move, antibiotics in rotation for bacterial overgrowth, and diet changes with a dietitian when weight drops.
Pain, itch and sleep
Pain relief depends on its source: warmth and vessel drugs for Raynaud pain, wound care for ulcers, physical and hand therapy for stiffness. Itch and sleep are handled case by case. This is where patients most often ask about cannabis, covered in is it worth raising.
Newer treatments under study (not cannabis)
Several studies in our reference list test other treatments. They are here because they describe the disease and its care, not because they say anything about cannabis.
Rituximab for SSc lung disease
A machine-learning analysis of the DESIRES trial found that people with C-reactive protein of at least 0.055 mg/dl tended to respond better at 24 weeks [9].
Guselkumab with SSc and psoriasis
Three Japanese patients with both conditions improved on 100 mg guselkumab over 6 months; there was no control group [10].
Measuring gut symptoms during IVIG
A Japanese version of the UCLA gut questionnaire proved reliable (Cronbach’s α 0.93) and picked up change after intravenous immunoglobulin [11].
Is systemic sclerosis fatal? Life expectancy, remission and whether it can be cured
Systemic sclerosis is a serious chronic disease, and in some people it can be life-threatening, mostly through the lungs, the heart, pulmonary hypertension or the kidneys. Many others live with it for decades with mainly skin and hand problems. The form, the organs involved and how early they are found make the difference.
How long can you live with systemic sclerosis?
There is no single number that applies to you. Outlook is generally better in the limited form and when the lungs and heart stay unaffected, and it has improved as screening and organ treatments have improved. The studies behind this page do not give survival figures, so we do not quote any. Your rheumatologist can estimate your own outlook from your antibody, your scans and how the disease has moved so far.
Can it go into remission, or be cured?
It cannot be cured yet. It can settle, though. In diffuse disease the skin often thickens most in the first few years and then softens partly on its own. Organ damage that has already happened usually stays, which is why early treatment and regular tests count.
Is systemic sclerosis a disability? SSA listing 14.04 and work
It can be. The Social Security Administration lists systemic sclerosis (scleroderma) as listing 14.04 in its Blue Book of impairments [12]. A diagnosis alone is not enough: the claim has to show how the disease limits you, for example through involvement of two or more organs or body systems with marked symptoms, or through hand and finger problems serious enough to stop you from doing fine and gross movements. Claims that do not meet the listing exactly can still be approved on what you are able to do.
What people usually gather for a claim
- Rheumatology notes that name the form, the antibody and the organs involved.
- Results over time: breathing tests, CT scans, echocardiograms, kidney tests.
- A doctor’s description of what your hands can and cannot do, and how often ulcers or flares take you out of work.
- Your own diary of bad days, Raynaud attacks and fatigue.
Records first
Claims stand on medical records, so ask for copies after each visit and keep them in one folder. The same folder serves a medical card evaluation later.
Adjusting work
Common accommodations: a warmer workspace, heated gloves, voice typing or an ergonomic keyboard, regular breaks, flexible hours on days with flares or appointments.
General information, not legal advice. A disability attorney or advocate can look at your own case.
With systemic sclerosis, is medical cannabis worth raising for you?
Fourteen short questions about your form of SSc, your organs, your medicines and what you hope to ease. The answer sorts what the research says for a situation like yours and what to take to your doctor.
14 questions · about a minute · your answers stay in this browser
Is medical cannabis worth raising with your rheumatologist?
For some symptoms, it is a fair question to bring. None of the studies cited here tested THC or CBD for any symptom of systemic sclerosis, and no cannabinoid has been shown to change the course of the disease. What a physician can weigh is a symptom that ordinary treatment leaves behind, against your organs and your medicine list. Pick the symptom that bothers you most.
Pain
Joint, tendon and ulcer pain are what most people mean. Chronic pain is a qualifying condition in many state programs. Ask how cannabis would fit next to your current pain relief.
Raynaud’s pain
Pain comes from vessels that clamp shut. Nothing here shows cannabis opens them. Ask whether your vessel medicines are at the right dose first.
Itch
Itch in early diffuse disease can wreck sleep. Skin cannabinoid research exists in other conditions, not SSc; ask what has been tried for yours.
Sleep
Reflux, itch and pain all break sleep. Ask which of them drives yours, since raising the head of the bed may matter more than anything taken.
Appetite and weight
Weight loss in SSc usually comes from a gut that moves poorly. That needs a gut workup before any appetite aid.
Mood
Low mood and worry are common with a chronic disease. THC can help some people relax and make anxiety worse in others; tell the physician about both.
When the topic is premature
- During a renal crisis, a new episode of breathlessness, or any hospital stay.
- While lung treatment is being chosen or changed for active interstitial lung disease.
- During pregnancy or while breastfeeding.
Why researchers study cannabinoids in scleroderma: CB1, CB2 and fibrosis
The body makes its own cannabis-like messengers, called endocannabinoids, and has receptors that respond to them. This is the endocannabinoid system, and it is present in skin and in fibroblasts, the cells that make collagen. Two receptors matter most. CB1 is the one THC acts on in the brain. CB2 sits mostly on immune cells and tends to quiet inflammation. A plain-language explainer is in the endocannabinoid system.
CB2: turning inflammation down in people, small trials
Lenabasum (also called ajulemic acid or anabasum) is a synthetic, oral drug that prefers CB2 and has little of the “high” THC gives. The idea was that switching CB2 on would calm the immune cells that push fibroblasts to make scar tissue. It reached Phase 2 trials in systemic sclerosis [13][14].
CB1: blocked, not switched on in mice
In mice whose skin was scarred with the drug bleomycin, a compound called MRI-1867 reduced fibrosis. It works by blocking CB1 (and the enzyme iNOS), not by activating it [15]. In that model, CB1 activity in the skin was part of the problem.
Endocannabinoid tone in mice
The same mouse work found raised endocannabinoid activity in scarred skin, which is why blocking CB1 lowered the scarring signal [15]. How this plays out in human skin is not known.
| Compound | CB1 | CB2 | Studied in SSc? |
|---|---|---|---|
| Lenabasum (synthetic trial drug) | little | ON | Small Phase 2 trials in people |
| MRI-1867 (lab compound) | OFF | none | Only in mice [15] |
| THC (in cannabis) | ON | ON | No |
| CBD (in cannabis and hemp) | weak | weak | No |
What the research on cannabinoids for systemic sclerosis shows, from strongest to weakest
In short: strong study designs are few. Individual small trials of the synthetic drug lenabasum were run in SSc; plant cannabis, THC and CBD products have not been tested in this disease.
A randomized trial can show whether a drug helps. A review summarizes other people’s work. An animal experiment suggests a mechanism. The table puts the cannabinoid work for SSc on those rungs.
| Level | What exists for SSc | What it can and cannot tell you |
|---|---|---|
| Trials in people | A Phase 2 trial of lenabasum in 41 people with SSc; the trials used 20 mg twice a day [13]. A 2020 report on a 12-week Phase 2 trial for skin disease in early diffuse SSc [14]. | Early, small, short. Results apply to this synthetic drug only. |
| Reviews | A 2020 review of new treatment targets that summarizes the CB2 results [16]. | Retells trial results, often without ranges. |
| Animal studies | MRI-1867, a CB1 blocker, in mice with bleomycin skin scarring [15]. | A possible mechanism; not a result in people. |
| Plant cannabis, THC, CBD | No studies in systemic sclerosis. | Nothing yet about benefit or harm in SSc specifically. |
What kinds of studies on systemic sclerosis are there?
How to read it: one row per type of published study on systemic sclerosis that we track, many of them about other treatments rather than cannabis. A longer bar means more studies of that type, strongest designs first. Gray bars are background work (narrative reviews, animal and cell studies), which can suggest ideas but cannot show that patients benefit.
Show as a table
| Design | Studies |
|---|---|
| Systematic reviews | 1 |
| Randomized trials | 2 |
| Other clinical trials | 4 |
| Cohort studies | 4 |
| Case-control studies | 2 |
| Cross-sectional studies | 1 |
| Case reports | 2 |
| Narrative reviews (background) | 12 |
| Animal studies (background) | 5 |
| Cell studies (background) | 2 |
Browse the studies cited here
One card per paper, in a sentence or two. Papers that study the disease or another drug carry a label so they are not mistaken for cannabis evidence.
Lenabasum for skin disease in early diffuse SSc
Skin scores fell 4.6 points with lenabasum and 2.0 with placebo; the 2.6-point gap did not pass the trial’s test (p 0.17, two-sided) [14].
Ajulemic acid, a CB2-preferring drug
Summarizes Phase 2 trials in SSc (41 patients), cystic fibrosis (85) and dermatomyositis (22), all at 20 mg twice a day; reported side effects included dizziness and headache [13].
New targets in SSc therapy
Reviews emerging treatments and reports a mean 9.2-point drop in skin score with a CB2 agonist, without a range [16].
MRI-1867 and bleomycin skin scarring
A CB1 and iNOS blocker reduced skin fibrosis in mice; bleomycin raised a drug pump in the skin that kept the compound out of the tissue [15].
Blood clots in SSc
Vein clots were about 3.5 times as frequent as in matched people without SSc, most of all in the first year [1].
How systemic sclerosis develops
Describes vessel injury, autoimmunity and fibrosis; about 250 patients per million in the US and a sibling risk about 15 times higher [3].
Antibody profiles in SSc
A protein array covering 65 antigens found anti-CENP-B in 32.2% and anti-topoisomerase I in 26.9% of Japanese SSc patients [6].
A new antibody test
Compared with 100 SSc and 50 dermatomyositis samples, conventional immunoblotting missed 19% of positives [7].
SSc with a rare inflammatory syndrome
A woman with both SSc and cryopyrin-associated periodic syndrome, studied with broad antibody profiling [17].
Rituximab for SSc lung disease
Baseline CRP and KL-6 helped predict who responded at 24 weeks [9].
Guselkumab in SSc with psoriasis
An IL-23 blocker improved both conditions in three patients [10].
Gut symptom score and IVIG
Validated a Japanese gut questionnaire and used it to track immunoglobulin treatment [11].
No studies of this type are cited here.
How big were the effects in the lenabasum trials, and what were they compared with?
The main measure was the modified Rodnan skin score (mRSS). A doctor pinches the skin at 17 body areas and grades each from 0 (normal) to 3 (very thick), so the total runs from 0 to 51 [5]. A falling score means softer skin. Trials also used CRISS, a combined score that adds lung function, overall well-being and the doctor’s view; the studies cited here give no CRISS numbers.
How much did skin scores change in the Phase 2 trial?
How to read it: each bar shows the average change in skin score over 12 weeks. Bars grow to the left from zero because a lower score means less thickening. The last row is the gap between the two groups, the part that can be credited to the drug.
Show as a table
| Comparison | Change in mRSS | Source |
|---|---|---|
| Lenabasum, 12 weeks | −4.6 points | Phase 2 trial report [14] |
| Placebo, 12 weeks | −2.0 points | Phase 2 trial report [14] |
| Difference | −2.6 points (SE 1.9; p 0.09 one-sided, 0.17 two-sided) | Phase 2 trial report [14] |
| As summarized in a 2020 review | −9.2 points, no range given | Narrative review [16] |
“Statistically significant” means a result is unlikely to be chance; this one was not. “Noticeable to the patient” is a separate question: a few points on a 51-point scale may or may not change how your hands feel. The review figure of 9.2 points comes without a range and may cover a longer, open period [16], so it does not replace the trial’s own comparison. Long-term results depend on later trials that the studies cited here do not cover.
A related trial in dermatomyositis, a different disease, reported a 5.6-point gain on its skin activity index (p 0.04) [13]. That does not transfer to SSc.
Lenabasum, MRI-1867 and what a medical card actually gets you
Four very different things get called cannabinoids in articles about scleroderma. Only one of them is what a medical card lets you buy, and it is the one nobody has studied in this disease.
| Name | What it is | Studied in SSc? | Where you would get it |
|---|---|---|---|
| Lenabasum (ajulemic acid) | Synthetic CB2-preferring drug taken by mouth | Small Phase 2 trials [13] | Nowhere outside a trial: not in pharmacies, not with a medical card |
| MRI-1867 | Lab compound that blocks CB1 and iNOS | Only in mice [15] | Not available |
| Dronabinol, nabilone, Epidiolex | FDA-approved prescription cannabinoids with fixed doses [18][19][20] | Not approved for SSc | Pharmacy, on a prescription; not a medical card product |
| THC and CBD products of a state program | Tested, labeled flower, oils, edibles, tinctures, topicals | No | Licensed medical dispensaries, with the card or recommendation your state accepts |
What a card gives you, then, is legal access to tested products and a physician’s review first, not access to a cannabis treatment that has been tested and shown to help in SSc.
Smoked, vaped, eaten, under the tongue or on the skin: what each form avoids and what stays with systemic sclerosis
Cannabis is not only smoked. Medical products are vaped, eaten, swallowed as capsules, dropped under the tongue, rubbed on the skin or worn as a patch. No study compares these forms in systemic sclerosis, so none is ranked here as gentler. What can be said is what each one avoids, what it keeps, and how that meets the organs SSc has reached in you. Choosing a form is a decision for you and a physician, not for this page.
What does SSc involve for you right now?
Your latest CT scan, breathing test and echocardiogram reports say whether the lungs and heart are involved. If you are not sure, ask your rheumatology team. Pick all that apply.
Which form are you asking about?
The names your state program uses on labels: flower for smoking, cartridges and concentrates for vaping, gummies and capsules, tinctures and sprays, creams and patches.
Pick a form to see what applies.
What it avoids
What stays
For what you picked
Smoking: joints, blunts, pipes, bongs
Avoids: a delayed start; the effect comes within minutes.
Stays: burning plant smoke in the airways, coughing, shared devices, every effect of THC, interactions.
Vaping and dabbing: dry-herb vaporizers, oil cartridges, concentrates
Avoids: burning plant matter.
Stays: hot aerosol in the same airways, cartridges of unknown content outside licensed stores, very strong concentrates, interactions.
Edibles, drinks and capsules
Avoids: smoke and aerosol in the lungs.
Stays: a late start and a long effect, the trap of a second dose taken because nothing happened yet, processing by the liver, interactions.
Tinctures, oils and mouth sprays
Avoids: smoke and aerosol; the dose is counted in drops or sprays.
Stays: part of each dose is swallowed and goes through the liver, interactions, drowsiness, dry mouth.
Creams, balms and transdermal patches
Avoids: the lungs and the gut; creams act mostly where applied.
Stays: skin reactions on thin, tight skin; patches deliver cannabinoids into the blood, so interactions and drowsiness stay.
Prescription cannabinoids: dronabinol, nabilone, Epidiolex
Avoids: unknown product content; the dose is fixed and printed on the label.
Stays: side effects and interactions listed on the FDA label [18][19][20]; none is approved for SSc, and they are filled at a pharmacy, not bought with a card.
Whatever the form
- THC and CBD reach the blood and can interact with the medicines your rheumatologist has set.
- THC can cause drowsiness, a faster heartbeat and dizziness when you stand up. Do not drive after using it.
- THC and CBD differ: a risk of one does not automatically carry over to a CBD-only product, or the other way round.
- Only tested, labeled products tell you what you are actually taking.
Notes by organ and form, as a table
| Organ | Inhaled (smoking, vaping) | Swallowed (edibles, capsules, tinctures, prescription) | On the skin (creams, patches) |
|---|---|---|---|
| Lungs (ILD or PAH) | Smoke and hot aerosol pass through the airways that interstitial lung disease scars. No study has measured inhaled cannabis in SSc lung disease. | Avoids the airways. THC can still speed the heart, which matters with pulmonary hypertension. | Creams avoid the airways; patches reach the blood, so heart effects stay. |
| Swallowing or reflux | Skips swallowing, but THC dries the mouth, already a common SSc complaint. | Capsules and dense edibles can be hard to get down. A slow gut can make the start of the effect less predictable, so a second dose taken early can stack. | Skips the gut; patches still enter the blood. |
| Heart or blood pressure | THC can raise the heart rate and drop blood pressure on standing within minutes. | The same heart and blood pressure effects, later and longer, adding to nifedipine or sildenafil. | Creams act mostly locally; patches carry the same effects as anything swallowed. |
| Kidneys | Keep up home blood pressure checks; feeling dizzy is a reason to measure, not to skip. | Vomiting after too large a dose costs fluid, which strains the kidneys. See acute kidney injury. | Little direct effect; keep the blood pressure checks. |
| Skin and fingers | Rheumatologists ask about smoke of any kind with Raynaud’s and finger ulcers; mention it. | Nothing specific beyond the notes for every form. | Nothing goes on open ulcers or broken skin without the wound care team; fragranced creams can irritate tight skin. |
Side effects and who should not use it · Pulmonary fibrosis and cannabis
Is cannabis safe with systemic sclerosis? Side effects and who should not use it
Nobody has followed people with SSc who use THC or CBD, so there is no measured safety record for this group. In the lenabasum work, dizziness and headache were the side effects noted, without frequencies [13]. The rest of what is known comes from general effects of THC and CBD, and from how they meet the organs SSc affects.
Dizziness and headache
The side effects reported with lenabasum [13]. THC can cause both too, especially early on or after a large dose.
Heart rate and blood pressure
THC can speed the heart and lower blood pressure on standing. With pulmonary hypertension or heart involvement, that is a strain to discuss first.
Drowsiness
THC sedates, and that adds to pain medicines, sleep aids and some drugs for itch.
Falls
Dizziness on standing plus stiff hands that cannot catch you well makes a fall likelier and its injuries worse.
Unknown products
Untested products, including delta-8 and unlabeled cartridges, may hold more THC than stated or other substances entirely.
Driving
THC slows reactions, and sedating medicines make it worse. Do not drive after using it.
Who should not use it, or only with the rheumatology team
- People with a known hypersensitivity to cannabinoids or their derivatives [13].
- Anyone in a renal crisis, with uncontrolled blood pressure, or with pulmonary hypertension that is not yet stable.
- People with active interstitial lung disease, for any inhaled form.
- Anyone pregnant, planning pregnancy or breastfeeding.
- People with a past psychosis or a family history of it, for THC.
- People on blood thinners or many interacting medicines, until the list has been checked. The higher clot risk in SSc is covered under complications.
Cannabis and scleroderma medicines: mycophenolate, nintedanib, nifedipine, sildenafil and blood thinners
People with SSc often take several medicines at once, so this is the most practical safety question. Only one finding in the research cited here is about interactions at all: lenabasum did not noticeably block the liver’s CYP enzymes [13]. That finding is about lenabasum only and does not carry over to THC or CBD products. What follows is what to ask, not a list of clashes measured in studies. Never stop or change a prescribed medicine on your own.
Pick the group your medicines belong to. If you are unsure, the name on each bottle tells you which group it is in.
Mycophenolate, methotrexate, cyclophosphamide
These protect the lungs and skin and need regular blood tests. Ask whether THC or CBD would change those tests or add to liver strain, and whether an infection risk from shared smoking devices matters while your immunity is lowered.
Nintedanib
It often causes diarrhea and can raise liver enzymes. Ask whether a cannabis product that also passes through the liver is sensible, and how liver tests would be followed.
Nifedipine, amlodipine, sildenafil, tadalafil, iloprost, bosentan
These lower blood pressure by widening vessels. THC can lower it further on standing, so dizziness can add up. Ask how to time doses and whether to check blood pressure more often at first.
Warfarin and newer blood thinners
The prescribing label for prescription CBD (Epidiolex) describes effects on liver enzymes that handle many drugs, and changes in warfarin levels have been reported [18]. Anyone on warfarin who starts CBD usually needs closer INR checks. Ask about your own thinner.
Omeprazole and other acid reducers, prokinetics
Some acid reducers and CBD share liver enzymes. Prokinetic drugs change how fast anything swallowed reaches the gut, so the timing of edibles can shift. Ask before combining.
Opioids, gabapentin, sleep aids, antihistamines for itch
Drowsiness adds up. Combined with THC, they slow breathing and reactions more than either alone. This is the overlap to raise first if you take any of them.
No medicines in this group are listed here.
Questions to ask about your medicine list
- Would THC or CBD change the dose or the blood tests for any of my medicines?
- Does my blood pressure medicine make dizziness from THC more likely?
- If I take a blood thinner, how often should levels be checked if I add CBD?
- Which of my medicines would add to drowsiness?
What science doesn’t know yet · Bring these to your rheumatologist
What science doesn’t know yet about cannabinoids and systemic sclerosis
For this disease the list of unknowns is longer than the list of findings, and the researchers say so themselves.
- The trials were mostly Phase 2, small and short; long-term benefit and safety rested on open-label extensions and later trials not covered here [13].
- No study has tested plant cannabis, THC or CBD products in people with SSc, for skin, pain or anything else.
- Nobody has measured what smoking or vaping does to the lungs of people with SSc-related lung disease.
- The mouse work did not separate how much of the benefit came from blocking CB1 and how much from blocking iNOS [15].
- The reviews summarize trials without pooling the numbers, so their figures cannot be compared directly [16].
- How CB1 and CB2 behave in human SSc skin over time is not mapped.
Three questions for any headline about cannabis and scleroderma
- Which molecule? Lenabasum and lab compounds are not what a dispensary sells.
- Which receptor, and which direction? Switching CB1 off is the opposite of what THC does.
- Which disease? A result in dermatomyositis, lupus or a mouse model is not a result in SSc.
An article that cannot answer these is a topic for your next visit, not a reason to start anything.
How to talk to your rheumatologist about cannabis: questions to bring
Tell every doctor about cannabis and CBD, the rheumatologist, the lung specialist and the emergency room alike, even if you use it only now and then. It does not change whether you get care. It can change which tests are ordered and which medicines are chosen. Rheumatologists hear the question often.
What to bring
Tap each item once it is in your folder.
Questions worth asking
- Given my lungs and heart, is any form of cannabis reasonable for me, and which should I avoid?
- Would THC or CBD interact with my current medicines or change my blood tests?
- Which symptom of mine might it reasonably be tried for, and how would we judge in a few weeks whether it helps?
- Is there anything in my case, such as kidney risk or pulmonary hypertension, that rules it out?
- If I go ahead, who do I call if something feels wrong?
What not to expect
Cannabis is not expected to slow skin or lung fibrosis, protect the kidneys or let you drop an immunosuppressant. If it has a place, it is next to your treatment, for a symptom, with a plan to check whether it is worth continuing.
Does systemic sclerosis qualify for a medical marijuana card?
Sometimes, and more often through a related condition than by name. State lists differ: most include chronic or severe pain in some form, and some let a physician certify other serious conditions. In every case a licensed physician decides after an evaluation, using the list your state has in force that day.
Rarely named
SSc by name
Few state lists spell out systemic sclerosis. Do not assume yours does.
A diagnosis in your records
A related condition
Chronic pain, a lung disease or another listed diagnosis can be the basis, if a doctor has recorded it.
Physician judgment
An open clause
Some programs let the physician certify a debilitating condition not on the list. Your state’s rules say whether yours does.
What else is in your medical records?
Programs count diagnoses written in your records, not symptoms alone. Pick what applies.
Chronic pain. The most widely listed condition. Bring notes on where it hurts, for how long, and what you have tried.
Raynaud’s with finger ulcers. Ulcers are wounds, and wound care notes help document severity. Research on cannabinoids and healing is collected under wounds.
Lung scarring. If your records say interstitial lung disease or pulmonary fibrosis, read pulmonary fibrosis and medical cannabis as well; the inhaled-form question applies there too.
Skin symptoms. Itch and inflamed skin are covered in skin inflammation and medical cannabis.
Slow stomach. If a gastroenterologist has named gastroparesis, see gastroparesis and medical cannabis.
None of these. The answer depends on how your state words its rules and on the physician’s judgment. Start with medical marijuana laws by state, or read getting a card without a listed condition.
Medical cannabis rules at a glance: what a medical card changes
Legal status, possession limits, taxes and home growing are set state by state and change often, so they are kept up to date on each state’s page rather than copied here. What a card changes in general:
Who looks at your health first
With a medical card
A licensed physician reviews your SSc, your organs and your medicines.
Buying without one
Nobody does.
Legal status
With a medical card
Legal purchase in every state with a medical program.
Buying without one
Legal only where adult sales are allowed.
Taxes and limits
With a medical card
In many states, lower taxes and higher possession limits for patients.
Buying without one
The full tax and the adult limit.
Home growing
With a medical card
Allowed for patients in some states, within set plant counts.
Buying without one
Allowed only where adult home growing is legal.
Exact limits, taxes and condition lists are on your state’s page in medical marijuana laws by state; the tax side is compared in medical vs recreational cannabis taxes.
Getting a medical card with systemic sclerosis: three steps and what happens next
The evaluation happens from home with a physician licensed in your state; you do not travel anywhere. Three steps are ours, and a fourth belongs to your state where it runs a registry. The full description is on the medical card page.
-
About 5 minutes
Fill in the form
Your state, your SSc diagnosis and form, the organs involved and every current medicine. Upload rheumatology notes if you have them.
-
About 15 minutes
See the physician
A one-on-one appointment online. You agree the time with the physician, who may run late with the patient before you, so keep an hour free around it.
-
In as little as 15 minutes after the appointment, depending on your state
Signed recommendation
If the physician finds medical cannabis appropriate, the document goes into your account.
-
Timing set by the state
State registration
Where a registry exists, you apply to the state, which issues the card on its own schedule.
Across 250 reviews from patients in the states where we are licensed. We do not sort them by score and do not hide the low ones.
- 150,000+patients evaluated – everyone who has been through an appointment with us, in every state where we are licensed
- Since 2017doing only this: online evaluations for medical cannabis programs, and nothing else on the side
You see the price for your state before paying; a state registration fee, where there is one, is paid to the state. Approval is never promised in advance, and what happens to the fee if the physician says no is answered in the medical card FAQ. Reduced prices exist for veterans and people with a low income. To move an appointment, use your appointments page; for a lost card, see what to do if your card was lost.
Our physicians are listed on the doctors page. A blood pressure spike, sudden breathlessness or a blackening fingertip needs emergency care, not an online appointment.
Systemic sclerosis FAQ
Is systemic sclerosis fatal? Can you die from it?
It can be, mainly when it seriously affects the lungs, the heart, the lung arteries or the kidneys. Many people, especially with the limited form, live for decades with mostly skin and hand problems. Early organ screening and treatment are what change the outlook; see outlook and remission.
How long can you live with systemic sclerosis?
There is no single figure. Life expectancy depends on the form, the antibody and which organs are involved, and it has improved with better screening. Your rheumatologist can estimate your own outlook from your scans and how the disease has behaved so far.
Is systemic sclerosis hereditary?
Not directly. Most people with SSc have no affected relative. Siblings do carry a higher risk, about 15 times the general population in one review, but because the disease is rare, any one sibling’s chance stays small [3].
Is systemic sclerosis chronic or acute?
Chronic. It is a long-term autoimmune disease that can flare and settle over years. Some complications, such as a renal crisis, come on suddenly and need emergency care.
Can systemic sclerosis be cured, or go into remission?
There is no cure. The disease can stabilize, and skin thickening in the diffuse form often softens after the first few years. Organ damage that has already happened usually stays, so treatment aims to prevent more.
Are systemic sclerosis and scleroderma the same?
Systemic sclerosis is one kind of scleroderma. Scleroderma also includes localized forms such as morphea that affect only the skin. Systemic sclerosis can involve internal organs; see what systemic sclerosis is.
Is CREST syndrome the same as systemic sclerosis?
CREST is an older name for limited cutaneous systemic sclerosis, so it is one form of it. The letters stand for calcinosis, Raynaud’s, esophageal problems, sclerodactyly and telangiectasias. Its ICD-10 code is M34.1 [4].
How rare is systemic sclerosis?
Does systemic sclerosis affect the brain?
Rarely directly. Nerve problems such as numbness in the hand or face can occur. A severe headache with vision changes may signal a renal crisis with very high blood pressure, which is an emergency.
Can systemic sclerosis affect the eyes?
Dry, gritty eyes are the most common problem, sometimes with Sjögren’s syndrome alongside. Tight eyelid skin can make blinking incomplete. Sudden vision changes with a headache need urgent care.
Can systemic sclerosis cause hair loss?
Usually only where the skin has thickened: hair there thins or stops growing. Widespread hair loss points to another cause, including some medicines, and is worth raising with your doctor.
Is systemic sclerosis painful?
It often is. Raynaud attacks, finger ulcers, stiff joints and tendons, calcinosis and reflux all cause pain, and fatigue makes it harder to cope with. See symptoms by body area.
What is the ICD-10 code for systemic sclerosis?
M34 is the group. M34.0 is progressive systemic sclerosis, M34.1 CR(E)ST syndrome, M34.81 SSc with lung involvement and M34.9 unspecified [4]. The older ICD-9 code was 710.1. The full list is in the code table.
What are the BSR guidelines for systemic sclerosis?
The British Society for Rheumatology guideline sets out organ-by-organ care: vessel drugs for Raynaud’s and ulcers, immunosuppression for skin and lungs, ACE inhibitors for renal crisis, and regular screening [8]. US rheumatologists use similar principles; see how it is treated.
Is systemic sclerosis a disability?
It can qualify. Social Security lists it as listing 14.04 in its Blue Book, and approval depends on how the disease limits you, shown in your medical records [12]. See disability and work.
Can you have systemic sclerosis and lupus at the same time?
Yes. Overlap syndromes combine features of SSc with lupus, myositis or rheumatoid arthritis. Mixed connective tissue disease is one such overlap. Treatment follows the features that are most active.
Is there a diet for systemic sclerosis bowel problems?
No single diet, but small frequent meals, staying upright after eating and avoiding late meals help reflux. Diarrhea or bloating from a slow gut may need treatment for bacterial overgrowth. A dietitian helps if weight falls.
Does CBD help scleroderma?
Can I smoke cannabis with scleroderma lung disease?
It is the form to be most careful with. Smoke and hot vapor pass through lungs that interstitial lung disease is already scarring, and no study has measured the effect in SSc. Edibles, tinctures and creams avoid the airways, but THC’s effects on heart rate and interactions remain with any form. Decide with your lung and rheumatology team; see forms and your organs.
Is lenabasum the same as CBD?
No. Lenabasum (ajulemic acid) is a synthetic drug built to act on the CB2 receptor, taken as a capsule in trials [13]. CBD is a natural compound from the cannabis plant with different targets. Results for one do not apply to the other.
Is delta-8 THC the same as medical cannabis?
No. Delta-8 products are usually made from hemp-derived CBD by chemical conversion and sold outside state medical programs, without the same testing. With organs that need careful monitoring, an untested product adds risk you do not need.
Does systemic sclerosis qualify for a medical marijuana card?
It can, usually through chronic pain or another listed condition in your records, or a state rule that allows physician judgment. A licensed physician decides after the evaluation. See does it qualify.
After a physician recommends medical cannabis, what happens next?
It depends on your state. In some, the signed recommendation is enough to buy from a licensed dispensary; in others you register with the state and wait for the card. Your state’s page in laws by state and the medical card FAQ explain it.
Is an online evaluation legal for a medical card?
In the states where we work, yes: the appointment is telemedicine with a physician licensed in your state, and the recommendation is the same document an office visit would produce. Your records and answers stay private under the same rules as any medical visit.
More research on cannabis and systemic sclerosis
This page cites a selection of studies. Our research library holds every study we track on cannabis and systemic sclerosis, from laboratory work to clinical trials, and lets you filter them by cannabinoid, study type and year.
- studies
- 60
- in people
- 28
- clinical trials
- 10
Talk to a licensed physician about medical cannabis for systemic sclerosis
What is known: a synthetic CB2 drug was tried in small trials, with a skin result that did not clearly beat placebo.
What is not known: whether THC or CBD products help any part of systemic sclerosis, or what smoke does to SSc lungs.
What a physician can do: look at your organs, your medicines and your state’s rules, and say whether cannabis makes sense for a symptom you live with.
You see the price for your state before paying, and the physician decides whether a recommendation is right. A blood pressure spike or sudden breathlessness: call 911 instead. This page is educational and does not replace care from your rheumatologist.
Share your experience
References
22 sources
- 1. Risk of Pulmonary Embolism and Deep Venous Thrombosis in Systemic Sclerosis: A General Population-Based Study. DOI: 10.1002/acr.22673 PMID: 26212772
- 2. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Scleroderma. 2024.
- 3. Pathogenesis of Systemic Sclerosis DOI: 10.3389/fimmu.2015.00272 PMID: 26106387
- 4. Centers for Medicare & Medicaid Services. ICD-10-CM code set. 2026.
- 5. American College of Rheumatology. Criteria: 2013 classification criteria for systemic sclerosis (ACR/EULAR). 2013.
- 6. Comprehensive autoantibody profiling in systemic autoimmunity by a highly-sensitive multiplex protein array. DOI: 10.3389/fimmu.2023.1255540 PMID: 37701440
- 7. The Autoantibody Array Assay: A Novel Autoantibody Detection Method. DOI: 10.3390/diagnostics13182929 PMID: 37761295
- 8. British Society for Rheumatology. Guideline for the treatment of systemic sclerosis. 2024.
- 9. Predictors of rituximab efficacy in systemic sclerosis-associated interstitial lung disease: machine-learning analysis of the DESIRES trial. DOI: 10.1093/rheumatology/keae716 PMID: 39718799
- 10. Impact of guselkumab on three cases of SSc accompanying psoriasis. DOI: 10.1093/rheumatology/kead287 PMID: 37310917
- 11. Reliability, validity, and sensitivity of the Japanese version of the University of California Los Angeles scleroderma clinical trial consortium gastrointestinal tract instrument: Application to efficacy assessment of intravenous immunoglobulin administration. DOI: 10.1111/1346-8138.17202 PMID: 38558171
- 12. Social Security Administration. Disability evaluation: 14.00 Immune system disorders, adult (14.04 Systemic sclerosis). 2024.
- 13. Ajulemic acid: potential treatment for chronic inflammation. DOI: 10.1002/prp2.394 PMID: 29638269
- 14. Lenabasum for skin disease in patients with diffuse cutaneous systemic sclerosis DOI: 10.1002/art.41302 PMID: 32368869
- 15. Peripheral Hybrid CB1R and iNOS Antagonist MRI-1867 Displays Anti-Fibrotic Efficacy in Bleomycin-Induced Skin Fibrosis. DOI: 10.3389/fendo.2021.744857 PMID: 34650521
- 16. Current and Potential New Targets in Systemic Sclerosis Therapy: a New Hope. DOI: 10.1007/s11926-020-00918-3 PMID: 32562016
- 17. Coexistence of systemic sclerosis and cryopyrin-associated periodic syndrome. DOI: 10.1111/1346-8138.17358 PMID: 38940218
- 18. U.S. Food and Drug Administration. Epidiolex (cannabidiol) prescribing information. 2018.
- 19. U.S. Food and Drug Administration. Marinol (dronabinol) prescribing information. 2017.
- 20. U.S. Food and Drug Administration. Cesamet (nabilone) prescribing information. 2006.
- 21. National Scleroderma Foundation. National Scleroderma Foundation. 2026.
- 22. U.S. National Library of Medicine. ClinicalTrials.gov. 2026.















